Daly Declan

Avg. Two Year Performance

(30%) Avg. Purchase Return
(14%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return17%45%(60%)(67%)(30%)
Purchase Success Rate1 of 22 of 20 of 20 of 21 of 2
Average Sale Return(10%)(12%)0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

Isolagen Inc.

Drugs » Drugs - Generic

COO & CFO, Director:

Holdings: 42.5K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--